NO20010659L - Vannløselige førdroger av hindrede alkoholer eller fenoler - Google Patents

Vannløselige førdroger av hindrede alkoholer eller fenoler

Info

Publication number: NO20010659L
Authority: NO; Norway
Prior art keywords: water; phenols; soluble precursors; hindered alcohols; soluble
Prior art date: 1998-08-07

Application number

NO20010659A

Other languages

English (en)

Other versions

NO330357B1 (no

NO20010659D0 (no

Inventor

Stella J Valentino

Jan J Zygmunt

Ingrid Gunda Georg

Muhammed S Safadi

Original Assignee

Univ Kansas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-08-07

Filing date

2001-02-07

Publication date

2001-04-06

2001-02-07 Application filed by Univ Kansas filed Critical Univ Kansas

2001-02-07 Publication of NO20010659D0 publication Critical patent/NO20010659D0/no

2001-04-06 Publication of NO20010659L publication Critical patent/NO20010659L/no

2011-04-04 Publication of NO330357B1 publication Critical patent/NO330357B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/06—Phosphorus compounds without P—C bonds
- C07F9/08—Esters of oxyacids of phosphorus
- C07F9/09—Esters of phosphoric acids
- C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/6552—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
- C07F9/65522—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
- C07K7/645—Cyclosporins; Related peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biophysics (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Anesthesiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Saccharide Compounds (AREA)
Pyrane Compounds (AREA)
Compounds Of Unknown Constitution (AREA)
Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
Steroid Compounds (AREA)

NO20010659A 1998-08-07 2001-02-07 Vannloselige, fenolinneholdende forbindelser og fremstilling derav, farmasoytisk sammensetning inneholdende disse, og anvendelse av forbindelsene i fremstilling av medikamenter NO330357B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US09/131,385 US6204257B1 (en)	1998-08-07	1998-08-07	Water soluble prodrugs of hindered alcohols
PCT/US1999/017779 WO2000008033A1 (en)	1998-08-07	1999-08-06	Water soluble prodrugs of hindered alcohols or phenols

Publications (3)

Publication Number	Publication Date
NO20010659D0 NO20010659D0 (no)	2001-02-07
NO20010659L true NO20010659L (no)	2001-04-06
NO330357B1 NO330357B1 (no)	2011-04-04

Family

ID=22449234

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20010659A NO330357B1 (no)	1998-08-07	2001-02-07	Vannloselige, fenolinneholdende forbindelser og fremstilling derav, farmasoytisk sammensetning inneholdende disse, og anvendelse av forbindelsene i fremstilling av medikamenter

Country Status (27)

Country	Link
US (4)	US6204257B1 (no)
EP (2)	EP1102776B1 (no)
JP (1)	JP4554081B2 (no)
KR (1)	KR100662799B1 (no)
CN (2)	CN1680402A (no)
AT (1)	ATE319723T1 (no)
AU (1)	AU769755B2 (no)
BR (1)	BR9912853A (no)
CA (1)	CA2339834C (no)
CY (1)	CY1105043T1 (no)
CZ (1)	CZ304020B6 (no)
DE (1)	DE69930269T2 (no)
DK (1)	DK1102776T3 (no)
ES (1)	ES2268876T3 (no)
HK (1)	HK1047939B (no)
HU (1)	HU229401B1 (no)
IL (1)	IL141316A (no)
MX (1)	MXPA01001431A (no)
NO (1)	NO330357B1 (no)
NZ (1)	NZ509795A (no)
PL (1)	PL198141B1 (no)
PT (1)	PT1102776E (no)
RU (1)	RU2235727C2 (no)
TR (1)	TR200100772T2 (no)
UA (1)	UA73479C2 (no)
WO (1)	WO2000008033A1 (no)
ZA (1)	ZA200101039B (no)

Families Citing this family (119)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6979456B1 (en)	1998-04-01	2005-12-27	Jagotec Ag	Anticancer compositions
US6204257B1 (en)	1998-08-07	2001-03-20	Universtiy Of Kansas	Water soluble prodrugs of hindered alcohols
ATE252889T1 (de)	1998-08-19	2003-11-15	Skyepharma Canada Inc	Injizierbare wässerige propofoldispersionen
US6362172B2 (en) *	2000-01-20	2002-03-26	Bristol-Myers Squibb Company	Water soluble prodrugs of azole compounds
US6362234B1 (en) *	2000-08-15	2002-03-26	Vyrex Corporation	Water-soluble prodrugs of propofol for treatment of migrane
US6448401B1 (en) *	2000-11-20	2002-09-10	Bristol-Myers Squibb Company	Process for water soluble azole compounds
RU2290196C2 (ru) *	2001-04-20	2006-12-27	Дебиофарм С.А.	Модифицированный циклоспорин, который можно использовать в качестве пролекарства, и его применение
WO2003026632A2 (en)	2001-09-26	2003-04-03	Theravance, Inc.	Substituted phenol compounds useful for anesthesia and sedation
CA2470423C (en) *	2001-12-21	2011-03-15	Guilford Pharmaceuticals, Inc.	Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
CA2470500C (en) *	2001-12-28	2012-05-15	Guilford Pharmaceuticals, Inc.	Aqueous based pharmaceutical formulations of water-soluble prodrugs of propofol
EP1492544A4 (en) *	2002-04-08	2005-10-12	Guilford Pharm Inc	PHARMACEUTICAL COMPOSITIONS CONTAINING PROPOFOL-BASED WATER-SOLUBLE PRODRUGS AND METHODS OF ADMINISTRATION THEREOF
ITRM20020306A1 (it)	2002-05-31	2003-12-01	Sigma Tau Ind Farmaceuti	Esteri in posizione 20 di camptotecine.
AU2002950713A0 (en)	2002-08-09	2002-09-12	Vital Health Sciences Pty Ltd	Carrier
ZA200504940B (en) *	2003-01-28	2006-09-27	Xenoport Inc	Amino acid derived prodrugs of propofol, compositions and uses thereof
JP2006524232A (ja)	2003-03-17	2006-10-26	アルバニーモレキュラーリサーチインコーポレーティッド	新規サイクロスポリン
AU2003901815A0 (en) *	2003-04-15	2003-05-01	Vital Health Sciences Pty Ltd	Phosphate derivatives
WO2005023204A2 (en) *	2003-09-09	2005-03-17	Xenoport, Inc.	Aromatic prodrugs of propofol, compositions and uses thereof
CN1882548A (zh) *	2003-10-24	2006-12-20	奥斯佩克斯制药公司	2,6－二异丙基苯酚的pH敏感性前药
US7834043B2 (en) *	2003-12-11	2010-11-16	Abbott Laboratories	HIV protease inhibiting compounds
BRPI0417472A (pt) *	2003-12-17	2007-05-08	Mgi Gp Inc	métodos para administração de prodrogas de propofol solúveis em água para sedação prolongada
US7232818B2 (en)	2004-04-15	2007-06-19	Proteolix, Inc.	Compounds for enzyme inhibition
CA2562411A1 (en)	2004-04-15	2005-11-10	Proteolix, Inc.	Compounds for enzyme inhibition
US8198270B2 (en) *	2004-04-15	2012-06-12	Onyx Therapeutics, Inc.	Compounds for proteasome enzyme inhibition
US20050256324A1 (en) *	2004-05-10	2005-11-17	Proteolix, Inc.	Synthesis of amino acid keto-epoxides
SG185963A1 (en) *	2004-05-10	2012-12-28	Onyx Therapeutics Inc	Compounds for enzyme inhibition
NZ590128A (en) *	2004-07-06	2012-08-31	Abbott Lab	Prodrugs of HIV protease inhibitors
DE602005010270D1 (de) *	2004-07-12	2008-11-20	Xenoport Inc	Von aminosäuren abgeleitete prodrugs von propofolzusammensetzungen und anwendungen davon
US7241807B2 (en) *	2004-07-12	2007-07-10	Xenoport, Inc.	Prodrugs of propofol, compositions and uses thereof
US20060014677A1 (en) *	2004-07-19	2006-01-19	Isotechnika International Inc.	Method for maximizing efficacy and predicting and minimizing toxicity of calcineurin inhibitor compounds
MX2007002210A (es) *	2004-08-26	2007-05-07	Nicholas Piramal India Ltd	Profarmacos que contienen enlazantes bioescindibles novedosos.
WO2006033911A2 (en) *	2004-09-17	2006-03-30	Mgi Gp, Inc.	Methods of administering water-soluble prodrugs of propofol
US7511013B2 (en)	2004-09-29	2009-03-31	Amr Technology, Inc.	Cyclosporin analogues and their pharmaceutical uses
JP2008514701A (ja)	2004-09-29	2008-05-08	エーエムアールテクノロジーインコーポレイテッド	シクロスポリンアルキン類似体およびそれらの薬学的使用
WO2006041631A2 (en)	2004-10-06	2006-04-20	Amr Technology, Inc.	Novel cyclosporin alkynes and their utility as pharmaceutical agents
CA2586410A1 (en) *	2004-12-23	2006-07-06	Xenoport, Inc.	Serine amino acid derived prodrugs of propofol, compositions, uses and crystalline forms thereof
CA2611831C (en)	2005-06-17	2014-09-16	Vital Health Sciences Pty Ltd.	A carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof
US20090221532A1 (en) *	2005-07-12	2009-09-03	Mgi Gp, Inc.	Methods Of Dosing Propofol Prodrugs For Inducing Mild To Moderate Levels Of Sedation
ES2441608T3 (es)	2005-08-18	2014-02-05	Zimmer Gmbh	Artículos de polietileno de peso molecular ultra-alto y métodos para formar artículos de polietileno de peso molecular ulra-alto
US20080234229A1 (en) *	2005-08-18	2008-09-25	Auspex Pharmaceuticals, Inc.	Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders
US7589239B2 (en) *	2005-09-02	2009-09-15	Auspex Pharmaceuticals	Therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
US20090114877A1 (en) *	2005-09-13	2009-05-07	Eisai R&D Management Co., Ltd.	Composition Containing Stability-Improved Chloromethyl Phosphate Derivatve and Process for Producing Same
US7687456B2 (en)	2005-11-09	2010-03-30	Proteolix, Inc.	Compounds for enzyme inhibition
EP2484688B1 (en) *	2006-06-19	2016-06-08	Onyx Therapeutics, Inc.	Peptide epoxyketones for proteasome inhibition
US20100311698A1 (en) *	2006-10-05	2010-12-09	Eisai Corporation Of North America	Aqueous based pharmaceutical formulations of water-soluable prodrugs of propofol
WO2008052044A2 (en) *	2006-10-26	2008-05-02	Xenoport, Inc.	Use of derivatives of propofol for treating diseases associated with oxidative stress
US8664290B2 (en)	2007-04-10	2014-03-04	Zimmer, Inc.	Antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
EP2150285B1 (en)	2007-04-10	2012-02-08	Zimmer, Inc.	An antioxidant stabilized crosslinked ultra-high molecular weight polyethylene for medical device applications
ES2501592T3 (es)	2007-05-09	2014-10-02	Sowood Healthcare Llc	Estereoisómero (-) de 2,6-di-sec-butilfenol y análogos del mismo para fomentar el efecto antiemético, tratamiento de náuseas y vómitos y tratamiento de migraña
EP2152651B1 (en)	2007-05-09	2012-01-04	Pharmacofore, Inc.	Therapeutic compounds
US20090005444A1 (en) *	2007-06-21	2009-01-01	Xenoport, Inc.	Use of propofol prodrugs for treating alcohol withdrawal, central pain, anxiety or pruritus
FI20070574A0 (fi) *	2007-07-30	2007-07-30	Kuopion Yliopisto	Vesiliukoinen propofolin etylideenifosfaatti-aihiolääke
US8427384B2 (en)	2007-09-13	2013-04-23	Aerosat Corporation	Communication system with broadband antenna
WO2009036305A1 (en) *	2007-09-13	2009-03-19	Aerosat Corporation	Communication system with broadband antenna
US20090076141A1 (en) *	2007-09-14	2009-03-19	Xenoport, Inc.	Use of Propofol Prodrugs for Treating Neuropathic Pain
US20090075947A1 (en) *	2007-09-17	2009-03-19	Protia, Llc	Deuterium-enriched fospropofol
MX2010003732A (es) *	2007-10-04	2010-08-09	Onyx Therapeutics Inc	Inhibidores de peptido cetona epoxi de proteasa cristalina y la sintesis de ceto-epoxidos de aminoacido.
US20090098209A1 (en) *	2007-10-15	2009-04-16	University Of Kansas	Pharmaceutical compositions containing water-soluble derivatives of propofol and methods of administering same via pulmonary administration
WO2009120162A1 (ru) *	2008-03-25	2009-10-01	Zhukovskij Oleg Igorevich	Субстанция "ua' orion"
MX2010012648A (es) *	2008-05-20	2010-12-14	Neurogesx Inc	Analogos de acetaminofeno solubles en agua.
JP5519645B2 (ja) *	2008-05-20	2014-06-11	ニューロジェシックス，インコーポレイテッド	カーボネートプロドラッグおよびそれを使用する方法
WO2010047737A2 (en)	2008-09-02	2010-04-29	Micurx Pharmaceuticals, Inc.	Antimicrobial indoline compounds for treatment of bacterial infections
PE20120059A1 (es)	2008-10-21	2012-02-27	Onyx Therapeutics Inc	Combinaciones farmaceuticas con epoxicetonas peptidicas
CN101798302B (zh)	2009-02-06	2014-11-05	上海盟科药业有限公司	抗生素类药物1-(邻-氟苯基)二氢吡啶酮的合成及生产的方法和工艺
TWI504598B (zh)	2009-03-20	2015-10-21	Onyx Therapeutics Inc	結晶性三肽環氧酮蛋白酶抑制劑
CN101845057B (zh) *	2009-03-27	2013-10-23	四川大学	取代苯酚的甲缩醛磷酸盐麻醉镇静药用化合物及制备方法
GB0905834D0 (en)	2009-04-03	2009-05-20	Seps Pharma Nv	Phosphonyl-containing phenolic derivatives useful as medicaments
US9150600B2 (en)	2009-05-07	2015-10-06	Regents Of The University Of Minnesota	Triptolide prodrugs
PL2427467T3 (pl) *	2009-05-07	2016-04-29	Univ Minnesota	Proleki tryptolidu
CN101648973B (zh) *	2009-09-03	2012-05-30	漆又毛	水溶性紫杉烷及制备方法
US8853147B2 (en)	2009-11-13	2014-10-07	Onyx Therapeutics, Inc.	Use of peptide epoxyketones for metastasis suppression
AU2011213557B2 (en)	2010-02-05	2015-05-07	Phosphagenics Limited	Carrier comprising non-neutralised tocopheryl phosphate
CN102153607B (zh) *	2010-02-11	2015-07-15	湖南方盛华美医药科技有限公司	水溶性喜树碱衍生物及包含其的药物组合物
US9359398B2 (en)	2010-03-01	2016-06-07	Onyx Therapeutics, Inc.	Compounds for immunoproteasome inhibition
EP2552486B1 (en)	2010-03-30	2020-08-12	Phosphagenics Limited	Transdermal delivery patch
WO2011136905A2 (en)	2010-04-07	2011-11-03	Onyx Therapeutics, Inc.	Crystalline peptide epoxyketone immunoproteasome inhibitor
RU2426541C1 (ru) *	2010-05-11	2011-08-20	Государственное образовательное учреждение дополнительного профессионального образования "Новокузнецкий государственный институт усовершенствования врачей Федерального агентства по здравоохранению и социальному развитию"	Способ профилактики послеоперационной тошноты и рвоты у детей в отоларингологической хирургии
US8399535B2 (en) *	2010-06-10	2013-03-19	Zimmer, Inc.	Polymer [[s]] compositions including an antioxidant
WO2012033952A1 (en)	2010-09-10	2012-03-15	Micurx Pharmaceuticals, Inc.	3 - phenyl- 2 -oxo- 1, 3 -oxazolidines for treatment of bacterial infections
RS54766B1 (sr) *	2010-12-02	2016-10-31	Univ Kansas	Prolekovi 6-cikloheksil-1-hidroksi-4-metilpiridin-2(1h)-ona i njegovih derivata
US9561243B2 (en)	2011-03-15	2017-02-07	Phosphagenics Limited	Composition comprising non-neutralised tocol phosphate and a vitamin A compound
ITMI20110580A1 (it) *	2011-04-08	2012-10-09	Chemelectiva S R L	Iintermedi utili per la preparazione di fospropofol e processo per la loro preparazione
UY34072A (es)	2011-05-17	2013-01-03	Novartis Ag	Derivados sustituidos de indol
US9024055B2 (en)	2011-09-22	2015-05-05	Acorda Therapeutics, Inc.	Acetaminophen conjugates, compositions and methods of use thereof
CN102516258B (zh) *	2011-11-11	2014-06-25	正大天晴药业集团股份有限公司	水溶性维生素e衍生物修饰的脂溶性抗癌药物化合物和制剂、该化合物的制备方法及应用
CN102382133B (zh) *	2011-12-02	2016-03-23	陕西合成药业股份有限公司	一种磷丙泊酚钠的制备及纯化方法
US9309283B2 (en)	2012-07-09	2016-04-12	Onyx Therapeutics, Inc.	Prodrugs of peptide epoxy ketone protease inhibitors
US9580459B2 (en) *	2013-04-26	2017-02-28	Metselex, Inc.	Water-soluble ursodeoxycholic acid prodrugs
WO2015050851A1 (en)	2013-10-01	2015-04-09	Zimmer, Inc.	Polymer compositions comprising one or more protected antioxidants
EP3099304B1 (en)	2014-01-31	2024-07-17	Mayo Foundation for Medical Education and Research	Chroman derivatives and their use in the treatment of glaucoma
WO2015127316A1 (en)	2014-02-21	2015-08-27	Micurx Pharmaceuticals, Inc.	Water-soluble o-carbonyl phosphoramidate prodrugs for therapeutic administration
EP3116941A1 (en)	2014-03-12	2017-01-18	Zimmer, Inc.	Melt-stabilized ultra high molecular weight polyethylene and method of making the same
JP6567049B2 (ja)	2014-10-21	2019-08-28	アッヴィ・インコーポレイテッド	カルビドパおよびｌ−ドーパプロドラッグならびにそれらの使用方法
CN107207741B (zh)	2014-12-03	2021-05-11	捷迈有限公司	注入抗氧剂的超高分子量聚乙烯
CN106674269A (zh) *	2015-11-11	2017-05-17	陕西合成药业股份有限公司	一种磷丙泊酚钠四水合物及晶型及其制备方法和用途
CN106674268A (zh) *	2015-11-11	2017-05-17	陕西合成药业股份有限公司	一种磷丙泊酚钠三水合物及晶型及其制备方法和用途
CN106674270A (zh) *	2015-11-11	2017-05-17	陕西合成药业股份有限公司	一种磷丙泊酚钠无水合物及晶型及其制备方法和用途
US10973761B2 (en)	2015-12-09	2021-04-13	Phosphagenics Limited	Pharmaceutical formulation
WO2017147146A1 (en) *	2016-02-23	2017-08-31	Concentric Analgesics, Inc.	Prodrugs of phenolic trpv1 agonists
WO2017184871A1 (en) *	2016-04-20	2017-10-26	Abbvie Inc.	Carbidopa and l-dopa prodrugs and methods of use
WO2017205632A1 (en) *	2016-05-27	2017-11-30	The Johns Hopkins University	Buccal, sublingual and intranasal delivery of fospropofol
US11929552B2 (en)	2016-07-21	2024-03-12	Astronics Aerosat Corporation	Multi-channel communications antenna
KR102647670B1 (ko)	2016-12-21	2024-03-15	아베초 바이오테크놀로지 리미티드	방법
US10992052B2 (en)	2017-08-28	2021-04-27	Astronics Aerosat Corporation	Dielectric lens for antenna system
US10174138B1 (en) *	2018-01-25	2019-01-08	University Of Massachusetts	Method for forming highly reactive olefin functional polymers
CA3117983A1 (en)	2018-11-15	2020-05-22	Abbvie Inc.	Pharmaceutical formulations for subcutaneous administration
CN109456360B (zh) *	2018-12-17	2021-05-14	河南中医药大学	一种磷丙泊酚钠的制备方法
CN113286796B (zh) *	2019-01-30	2024-07-05	四川科伦博泰生物医药股份有限公司	喜树碱衍生物及其水溶性前药、包含其的药物组合物及其制备方法和用途
US11547714B2 (en)	2020-02-05	2023-01-10	Epalex Corporation	Fospropofol salts, methods and compositions
US11628178B2 (en)	2019-03-26	2023-04-18	Epalex Corporation	Fospropofol methods and compositions
US11439653B1 (en)	2021-03-30	2022-09-13	Epalex Corporation	Fospropofol formulations
US11478490B1 (en)	2021-03-30	2022-10-25	Epalex Corporation	Fospropofol formulations
JP7636742B2 (ja)	2019-12-12	2025-02-27	クラリスバイオインコーポレイテッド	制御送達性クロマカリムプロドラッグ
WO2021228150A1 (zh) *	2020-05-13	2021-11-18	成都百裕制药股份有限公司	大麻素衍生物及其制备方法和在医药上的应用
WO2022217022A1 (en)	2021-04-10	2022-10-13	Profoundbio Us Co.	Folr1 binding agents, conjugates thereof and methods of using the same
CN117203238A (zh)	2021-04-23	2023-12-08	普方生物制药美国公司	Cd70结合剂、其偶联物及其使用方法
TW202320857A (zh)	2021-07-06	2023-06-01	美商普方生物製藥美國公司	連接子、藥物連接子及其結合物及其使用方法
AR133955A1 (es)	2023-09-26	2025-11-19	Profoundbio Us Co	Agentes de unión a ptk7, conjugados de éstos y métodos de uso de los mismos
WO2025149661A1 (en)	2024-01-10	2025-07-17	Genmab A/S	Slitrk6 binding agents, conjugates thereof and methods of using the same
WO2025181219A1 (en)	2024-02-29	2025-09-04	Genmab A/S	Egfr and c-met bispecific binding agents, conjugates thereof and methods of using the same

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2829151A (en)	1952-11-03	1958-04-01	Dow Chemical Co	Chlorotoloxy-ethyl phosphates
US3271314A (en)	1958-12-04	1966-09-06	Ethyl Corp	2, 6-diisopropylphenol
GB1146173A (en)	1966-06-18	1969-03-19	Geigy Uk Ltd	Production of triaryl phosphates
US3723578A (en)	1970-10-13	1973-03-27	Gaf Corp	Phosphate esters of ethers of thiol substituted phenols
US4171272A (en)	1977-12-02	1979-10-16	Fmc Corporation	Turbine lubricant
FR2601259B1 (fr)	1986-07-11	1990-06-22	Rhone Poulenc Chimie	Nouvelles compositions tensio-actives a base d'esters phosphoriques leur procede de preparation et leur application a la formulation de matieres actives.
US4894456A (en)	1987-03-31	1990-01-16	Research Triangle Institute	Synthesis of camptothecin and analogs thereof
US5364858A (en)	1987-03-31	1994-11-15	Research Triangle Institute	Camptothecin analogs as potent inhibitors of topoisomerase I
US5106742A (en)	1987-03-31	1992-04-21	Wall Monroe E	Camptothecin analogs as potent inhibitors of topoisomerase I
US5122526A (en)	1987-03-31	1992-06-16	Research Triangle Institute	Camptothecin and analogs thereof and pharmaceutical compositions and method using them
US4981968A (en)	1987-03-31	1991-01-01	Research Triangle Institute	Synthesis of camptothecin and analogs thereof
US5053512A (en)	1987-04-14	1991-10-01	Research Triangle Institute	Total synthesis of 20(S) and 20(R)-camptothecin and compthothecin derivatives
US5244903A (en)	1987-03-31	1993-09-14	Research Triangle Institute	Camptothecin analogs as potent inhibitors of topoisomerase I
US5180722A (en)	1987-04-14	1993-01-19	Research Triangle Institute	10,11-methylenedioxy-20(RS)-camptothecin and 10,11-methylenedioxy-20(S)-camptothecin analogs
US5122606A (en)	1987-04-14	1992-06-16	Research Triangle Institute	10,11-methylenedioxy camptothecins
US5049668A (en)	1989-09-15	1991-09-17	Research Triangle Institute	10,11-methylenedioxy-20(RS)-camptothecin analogs
MY103951A (en)	1988-01-12	1993-10-30	Kao Corp	Detergent composition
CA2014539C (en)	1989-04-17	2000-07-25	Shinichiro Umeda	Water borne metallic coating composition
US5091211A (en)	1989-08-17	1992-02-25	Lord Corporation	Coating method utilizing phosphoric acid esters
JPH03209414A (ja)	1990-01-12	1991-09-12	Nikon Corp	焦点調節装置
ES2088435T3 (es)	1990-10-17	1996-08-16	Tomen Corp	Procedimiento y composicion para mejorar la absorcion y transporte de agentes bioactivos en plantas.
US5646176A (en)	1992-12-24	1997-07-08	Bristol-Myers Squibb Company	Phosphonooxymethyl ethers of taxane derivatives
CA2111527C (en)	1992-12-24	2000-07-18	Jerzy Golik	Phosphonooxymethyl ethers of taxane derivatives
CA2129288C (en)	1993-08-17	2000-05-16	Jerzy Golik	Phosphonooxymethyl esters of taxane derivatives
US5731356A (en) *	1994-03-22	1998-03-24	Zeneca Limited	Pharmaceutical compositions of propofol and edetate
US5786344A (en) *	1994-07-05	1998-07-28	Arch Development Corporation	Camptothecin drug combinations and methods with reduced side effects
US5646159A (en)	1994-07-20	1997-07-08	Research Triangle Institute	Water-soluble esters of camptothecin compounds
IT1270093B (it)	1994-09-28	1997-04-28	Zambon Spa	Processo per la purificazione di 2,6-diisopropilfenolo
TW354293B (en)	1995-06-06	1999-03-11	Bristol Myers Squibb Co	Prodrugs of paclitaxel derivatives
US5804682A (en)	1995-11-29	1998-09-08	Henkel Corporation	Aqueous dispersions of polyamides
US5637625A (en)	1996-03-19	1997-06-10	Research Triangle Pharmaceuticals Ltd.	Propofol microdroplet formulations
US5746973A (en)	1996-07-10	1998-05-05	Naraghi; Ali	Method for reducing odorant depletion
JP2002501926A (ja) *	1998-01-29	2002-01-22	ブリストル−マイヤーズスクイブカンパニー	ジアリール１、３、４−オキサジアゾロンのホスフェート誘導体
US6204257B1 (en) *	1998-08-07	2001-03-20	Universtiy Of Kansas	Water soluble prodrugs of hindered alcohols

1998
- 1998-08-07 US US09/131,385 patent/US6204257B1/en not_active Expired - Lifetime
1999
- 1999-06-08 UA UA2001031520A patent/UA73479C2/uk unknown
- 1999-08-06 EP EP99939030A patent/EP1102776B1/en not_active Expired - Lifetime
- 1999-08-06 ES ES99939030T patent/ES2268876T3/es not_active Expired - Lifetime
- 1999-08-06 RU RU2001106614/04A patent/RU2235727C2/ru not_active IP Right Cessation
- 1999-08-06 WO PCT/US1999/017779 patent/WO2000008033A1/en not_active Ceased
- 1999-08-06 NZ NZ509795A patent/NZ509795A/en not_active IP Right Cessation
- 1999-08-06 MX MXPA01001431A patent/MXPA01001431A/es active IP Right Grant
- 1999-08-06 HK HK03100006.9A patent/HK1047939B/zh not_active IP Right Cessation
- 1999-08-06 DE DE69930269T patent/DE69930269T2/de not_active Expired - Lifetime
- 1999-08-06 HU HU0200317A patent/HU229401B1/hu not_active IP Right Cessation
- 1999-08-06 CA CA2339834A patent/CA2339834C/en not_active Expired - Fee Related
- 1999-08-06 CN CNA2005100524949A patent/CN1680402A/zh active Pending
- 1999-08-06 JP JP2000563666A patent/JP4554081B2/ja not_active Expired - Fee Related
- 1999-08-06 PL PL347211A patent/PL198141B1/pl unknown
- 1999-08-06 KR KR1020017001674A patent/KR100662799B1/ko not_active Expired - Fee Related
- 1999-08-06 IL IL14131699A patent/IL141316A/en not_active IP Right Cessation
- 1999-08-06 CZ CZ20010479A patent/CZ304020B6/cs not_active IP Right Cessation
- 1999-08-06 AT AT99939030T patent/ATE319723T1/de active
- 1999-08-06 DK DK99939030T patent/DK1102776T3/da active
- 1999-08-06 CN CNB998114405A patent/CN1198834C/zh not_active Expired - Fee Related
- 1999-08-06 AU AU53394/99A patent/AU769755B2/en not_active Ceased
- 1999-08-06 TR TR2001/00772T patent/TR200100772T2/xx unknown
- 1999-08-06 BR BR9912853-5A patent/BR9912853A/pt not_active Application Discontinuation
- 1999-08-06 PT PT99939030T patent/PT1102776E/pt unknown
- 1999-08-06 EP EP06004146A patent/EP1683803A1/en not_active Withdrawn
2000
- 2000-12-08 US US09/733,817 patent/US6451776B2/en not_active Expired - Lifetime
2001
- 2001-02-07 NO NO20010659A patent/NO330357B1/no not_active IP Right Cessation
- 2001-02-07 ZA ZA200101039A patent/ZA200101039B/en unknown
2002
- 2002-07-29 US US10/208,647 patent/US6872838B2/en not_active Expired - Fee Related
2004
- 2004-11-17 US US10/991,348 patent/US7244718B2/en not_active Expired - Fee Related
2006
- 2006-06-02 CY CY20061100710T patent/CY1105043T1/el unknown

Also Published As

Publication number	Publication date
HU229401B1 (en)	2013-12-30
US7244718B2 (en)	2007-07-17
JP4554081B2 (ja)	2010-09-29
HK1047939B (zh)	2005-11-18
HUP0200317A2 (en)	2002-06-29
US6451776B2 (en)	2002-09-17
ES2268876T3 (es)	2007-03-16
DE69930269D1 (de)	2006-05-04
CN1198834C (zh)	2005-04-27
CN1680402A (zh)	2005-10-12
DE69930269T2 (de)	2006-12-07
AU5339499A (en)	2000-02-28
CZ2001479A3 (cs)	2001-09-12
NZ509795A (en)	2003-10-31
AU769755B2 (en)	2004-02-05
IL141316A (en)	2004-06-20
EP1102776B1 (en)	2006-03-08
US20050090431A1 (en)	2005-04-28
CA2339834C (en)	2011-01-25
US6872838B2 (en)	2005-03-29
HUP0200317A3 (en)	2004-07-28
BR9912853A (pt)	2001-10-30
CA2339834A1 (en)	2000-02-17
PL198141B1 (pl)	2008-05-30
RU2235727C2 (ru)	2004-09-10
ATE319723T1 (de)	2006-03-15
WO2000008033A1 (en)	2000-02-17
TR200100772T2 (tr)	2001-12-21
PT1102776E (pt)	2007-02-28
KR100662799B1 (ko)	2007-01-02
US20010025035A1 (en)	2001-09-27
EP1683803A1 (en)	2006-07-26
UA73479C2 (uk)	2005-08-15
EP1102776A1 (en)	2001-05-30
DK1102776T3 (da)	2006-07-10
HK1047939A1 (en)	2003-03-14
US20030176324A1 (en)	2003-09-18
NO330357B1 (no)	2011-04-04
JP2002522443A (ja)	2002-07-23
CY1105043T1 (el)	2010-03-03
CN1357000A (zh)	2002-07-03
MXPA01001431A (es)	2002-11-29
KR20010079627A (ko)	2001-08-22
ZA200101039B (en)	2002-02-05
PL347211A1 (en)	2002-03-25
IL141316A0 (en)	2002-03-10
NO20010659D0 (no)	2001-02-07
US6204257B1 (en)	2001-03-20
CZ304020B6 (cs)	2013-08-28

Publication	Publication Date	Title
NO20010659L (no)	2001-04-06	Vannløselige førdroger av hindrede alkoholer eller fenoler
EP1760067A3 (en)	2007-05-30	Compounds with protected hydroxy groups
IL143747A0 (en)	2002-04-21	Substituted aryl or heteroarylamides having retinoid-like biological activity
PT928799E (pt)	2005-08-31	Utilizacao de isocianatos especiais para a preparacao de revestimentos aquosos de poliuretano
FI970246A7 (fi)	1997-01-21	Dihydrobentsofuraanit
ES2081716T3 (es)	1996-03-16	Procedimiento para la fabricacion de resina de organopolisiloxano.
DE69712984D1 (de)	2002-07-11	Verfahren zur Herstellung von 6-Methyl-2-Heptanon Analogen, und Verfahren zur Herstellung von Phyton und Isophytol
BG102215A (en)	1998-09-30	Compounds and pharmaceutical compositions containing them
DE69509161D1 (de)	1999-05-27	Hydroxylgruppen enthaltende Triaminkatalysatorzusammensetzungen zur Polyurethanherstellung
BE893790A (fr)	1983-01-07	Preparation de cetones aromatiques
TR199802255T2 (xx)	1999-02-22	Eklembacakl�lar� uzakla�t�ran maddeler.
DE69926379D1 (de)	2005-09-01	Verfahren zur herstellung von 2-(2,4-dihydroxyphenyl) or 2-(2,4-dialkoxyphenyl) -4,6-bisaryl-1,3,5-triazine
ES2161446T3 (es)	2001-12-01	Taxoides, su preparacion y las composiciones farmaceuticas que les contienen.
DE60201695D1 (de)	2004-12-02	Verfahren zur Herstellung von Monoarylalkylethern
ES2186191T3 (es)	2003-05-01	Productos de reaccion del acido fosfonico y su uso en composiciones de recubrimiento.
PT894500E (pt)	2004-10-29	Vacina para streptococcus equi
FI851881A0 (fi)	1985-05-13	Foerfarande foer framstaellning av aromatiska n-acylhydroxi- och n-acyl-acyloxiaminer.
BR9907697A (pt)	2000-11-14	Carbonatos de serina
ES516362A0 (es)	1983-06-16	"procedimiento para la preparacion de un oligomero de un disocianato alifatico".
DK1062223T3 (da)	2007-11-12	Præparat som indeholder en precursor der kan hydrolyseres af glucocerebrosidase
GB9025890D0 (en)	1991-01-09	Pharmaceutical compounds
BR0011111A (pt)	2002-02-19	Processos para a preparação de 1,3,5-ciclo-hexanotrionas 2,2,4,4- tetrassubstituìdas, para a preparaçãp de ésteres enol silìlicos, composto,uso de ciclobutano-1,3-dionas
NO994107L (no)	1999-08-25	Preparater for behandling eller forhindring av prostatakreft
DE69105901D1 (de)	1995-01-26	Verfahren zur Herstellung von aromatischen Hydroxyverbindungen.
FI953621L (fi)	1996-01-30	Eliprodiilin ja sen enantiomeerien käyttö lääkeaineiden valmistukseen, jotka lääkeaineet ovat käyttökelpoisia syövän vastaisten aineiden aiheuttamien neuropatiatilojen estämiseen

Legal Events

Date	Code	Title	Description
2017-03-20	MM1K	Lapsed by not paying the annual fees